Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: primary care providers

Advocating for Arthritis: My First Time on the Hill

Colin C. Edgerton, MD  |  July 1, 2010

Amidst the most momentous week of the year’s tumultuous healthcare reform activities, we arrived in Washington, D.C., for the annual ACR Advocates for Arthritis Capitol Hill Fly-In. This was to be my first visit to Congress. Although my alma mater, Georgetown University, was a short distance from the Capitol dome, as a student I had little interest in the political process—particularly as it related to medicine. Now, however, as a young rheumatologist, I am increasingly aware of the impact health policy has on my daily practice. I have also watched the healthcare reform debate unfold over the last year, recognizing that this is a critical time for physicians to be vocal and active. There is a great deal at stake, and we are surrounded daily by the very issues debated in Washington. Why not take our opinions directly to the decision makers?

Filed under:From the CollegeLegislation & AdvocacyProfessional Topics Tagged with:AdvocacyAdvocates for ArthritisAdvocating with YouCongressLegislationPolitics

The ACR Benchmark Survey Results

From the College  |  June 1, 2010

In 2009, the ACR’s Committe­e on Rheumatologic Care (CORC) began its third Economic Benchmark Survey to update information from the previous surveys conducted in 1999 and 2003.

Filed under:From the CollegePractice SupportWorkforce Tagged with:CORCPractice Management

Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  May 1, 2010

Information on New Approvals and Medication Safety

Filed under:Drug Updates Tagged with:ApprovalsDrugsMedicationPipelineSafety

Update on Meaningful Use

From the College  |  March 1, 2010

On December 30, the U.S. Department of Health and Human Services (HHS) released the long-awaited proposed rule establishing the Electronic Health Record (EHR) Incentive Program, which lays out a set of standards, implementation specifications, and certification criteria for EHR technology. This program has been developed in response to the “American Recovery and Reinvestment Act” (ARRA), which authorizes the Centers for Medicare & Medicaid Services to provide a reimbursement incentive for physician and hospital providers who become “meaningful users” of an EHR.

Filed under:EMRsFrom the CollegePractice SupportTechnology Tagged with:ARRACenters for Medicare & Medicaid Services (CMS)EHREMRHHSPractice Page

A Sobering Reality in Sierra Leone

Natasha M. Ruth, MD, and Gary S. Gilkeson, MD  |  March 1, 2010

Trip to focus on lupus takes on another purpose

Filed under:ProfilesSystemic Lupus Erythematosus Tagged with:InternationalVolunteer

H1N1 Influenza A Virus Brings Many Questions, Few Answers

Kurt Ullman  |  November 1, 2009

Rheumatologists grapple with vaccine concerns and the impact of medications on response

Filed under:Drug Updates Tagged with:FluImmunityInfectionvaccination

Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  September 1, 2009

Information on New Approvals and Medication Safety

Filed under:Drug Updates Tagged with:acetaminophenApprovalsFDALabeling ChangesPipeline

REMS Required

Vanessa Caceres  |  August 1, 2009

How will this FDA drug safety program affect rheumatology offices?

Filed under:Practice Support Tagged with:FDAMedicationREMSSafetyTreatment

Quality Measures and Reporting

Sherine Gabriel, MD  |  March 1, 2009

A call for professional responsibility

Filed under:President's Perspective Tagged with:Centers for Medicare & Medicaid Services (CMS)EHREMRQuality

Members Comment on Drug Safety

Staff  |  February 1, 2009

The ACR recently conducted a survey of U.S. members about the issue of drug safety, sources of information, and related issues. The survey netted 454 responses.

Filed under:From the College Tagged with:Drug SafetyQuality Measures

  • « Previous Page
  • 1
  • …
  • 42
  • 43
  • 44
  • 45
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences